Holen Sie sich die Stockscreener-App
29.19
0.62%
0.18
Vorhandelsmarkt:
29.25
0.06
+0.21%
Schlusskurs vom Vortag:
$29.01
Offen:
$29.09
24-Stunden-Volumen:
888.67K
Relative Volume:
1.11
Marktkapitalisierung:
$1.29B
Einnahmen:
$78.02M
Nettoeinkommen (Verlust:
$-73.37M
KGV:
-22.11
EPS:
-1.32
Netto-Cashflow:
$-62.06M
1W Leistung:
-3.98%
1M Leistung:
+6.18%
6M Leistung:
+51.48%
1J Leistung:
+0.00%
1-Tages-Spanne:
$28.01
$29.67
1-Wochen-Bereich:
$28.00
$31.51
52-Wochen-Spanne:
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Vergleichen Sie BBNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
29.19 | 1.28B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Beta Bionics stock rating reiterated at Buy by Stifel - Investing.com India
Beta Bionics: It Has Been An Interesting Year (NASDAQ:BBNX) - Seeking Alpha
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - The Manila Times
This Beta Bionics Insider Increased Their Holding By 130% Last Year - simplywall.st
Feider Stephen (Beta Bionics) sells $41,862 in shares By Investing.com - Investing.com Canada
Top Executives at Beta Bionics, Inc. Cash Out on Stock Sales - TipRanks
Mensinger, Beta Bionics CPO, sells $31k in BBNX stock By Investing.com - Investing.com Nigeria
Feider Stephen (Beta Bionics) sells $41,862 in shares - Investing.com
Beta Bionics Executives Sell Shares for Tax Obligations - TradingView
Officer Mensinger Files To Sell 1,063 Of Beta Bionics Inc [BBNX] - TradingView
With Beta Bionics Stock Sliding, Have You Assessed The Risk? - Trefis
Insider Sell Alert: Adam Lezack Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Beta Bionics Executives Sell Shares - TradingView
Beta Bionics (BBNX) Stock Analysis Report | Financials & Insights - Benzinga
Tech Watch: The Latest in Diabetes Tech News - Making Sense of Diabetes
BBNX Crosses Above Average Analyst Target - Nasdaq
Why Beta Bionics Inc. stock is a value investor pickJuly 2025 Snapshot & Free Safe Entry Trade Signal Reports - BỘ NỘI VỤ
Corporate – Shares – Settlement - Massachusetts Lawyers Weekly
Technical Analysis of Beta Bionics, Inc. (NASDAQ:BBNX) - TradingView
Why Beta Bionics Inc. stock is a must watch in 2025Trade Risk Summary & High Return Stock Watch Alerts - BỘ NỘI VỤ
What analysts say about Beta Bionics Inc stockMid Cap Growth Trends & Compound Your Gains With Quality Stocks - earlytimes.in
How currency fluctuations impact Beta Bionics Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Using economic indicators to assess Beta Bionics Inc. potentialMarket Volume Report & Stock Timing and Entry Methods - newser.com
How institutional buying supports Beta Bionics Inc. stockWeekly Market Summary & Real-Time Price Movement Reports - newser.com
Will Beta Bionics Inc. continue its uptrendStop Loss & Fast Gaining Stock Strategy Reports - newser.com
Regression analysis insights on Beta Bionics Inc. performanceWeekly Investment Report & Weekly Top Gainers Alerts - newser.com
How supply chain issues affect Beta Bionics Inc. stockJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - newser.com
Beta Bionics Inc. stock chart pattern explainedJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Is Beta Bionics Inc. stock positioned for long term growthJuly 2025 Big Picture & Risk Controlled Daily Plans - newser.com
Will Beta Bionics Inc. price bounce be sustainableWeekly Risk Summary & AI Powered Market Trend Analysis - newser.com
Fourteen new option listings on November 12th - MSN
Beta Bionics (BBNX) Price Target Increased by 23.23% to 31.93 - Nasdaq
Visual trend scoring systems applied to Beta Bionics Inc.Stop Loss & Long-Term Growth Stock Strategies - newser.com
Is now a turning point for Beta Bionics Inc.July 2025 Retail & Weekly High Return Stock Opportunities - newser.com
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):